Department of Ultrasound, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
National Clinical Research Center for Child Health, The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Front Endocrinol (Lausanne). 2022 Jun 16;13:884428. doi: 10.3389/fendo.2022.884428. eCollection 2022.
The BRAF V600E mutation is the most common genetic variant in papillary thyroid cancer (PTC), but the relationship between the BRAF V600E mutation in PTC and cervical lymph node metastasis (LNM) remains controversial.
To estimate risk factors for neck nodal metastasis in PTC with BRAF V600E mutation.
A total of 292 patients diagnosed with BRAF V600E mutation related PTC were admitted.
In this retrospective study, data from 292 patients, including clinical, molecular, and ultrasonic characteristics, were analyzed. Univariate and multivariate logistic regression analyses were applied to identify risk factors for LNM in PTC with the V600E mutation.
In the univariate analysis of all PTC patients with the BRAF V600E mutation, the LNM was found to be significantly associated with age ( = 0.010), size ( = 0.000), bilaterality ( = 0.000), multifocality ( = 0.002), LNM in ultrasound (US) ( = 0.000), and capsular invasion ( = 0.010). In ultrasonic image characteristics, margin ( = 0.036), shape ( = 0.046), and microcalcification ( = 0.002) were significantly associated with LNM. In multivariate analysis, LNM in PTCs with BRAF V600E mutation was significantly associated with age ≤ 45 years (OR = 1.869, = 0.020, 95% CI = 1.106 - 3.158), size ≥ 1cm (OR = 3.131, = 0.001, 95% CI = 1.578 - 6.212), LNM in US (OR = 6.962, = 0.000, 95% CI = 2.924 - 16.572), bilaterality (OR = 1.626, = 0.007, 95% CI = 1.142 - 2.314), ill-defined margins in US (OR = 1.980, = 0.033, 95% CI = 1.057 - 3.709), and microcalcification in US (OR = 2.786, = 0.002, 95% CI = 1.464 - 5.303).
This study revealed that several significant risk factors for LNM in PTCs with the BRAF V600E mutation included: age ≤ 45 years, size ≥ 1cm, LNM in US, bilaterality, ill-defined margins in US, and microcalcification in US.
BRAF V600E 突变是甲状腺乳头状癌(PTC)中最常见的遗传变异,但 PTC 中 BRAF V600E 突变与颈部淋巴结转移(LNM)之间的关系仍存在争议。
评估 BRAF V600E 突变相关 PTC 发生颈部淋巴结转移的风险因素。
共纳入 292 例诊断为 BRAF V600E 突变相关 PTC 的患者。
在这项回顾性研究中,分析了 292 例患者的临床、分子和超声特征数据。应用单因素和多因素逻辑回归分析来确定 BRAF V600E 突变相关 PTC 发生 LNM 的风险因素。
在所有 BRAF V600E 突变相关 PTC 患者的单因素分析中,LNM 与年龄( = 0.010)、大小( = 0.000)、双侧性( = 0.000)、多灶性( = 0.002)、超声(US)中的 LNM( = 0.000)和包膜侵犯( = 0.010)显著相关。在超声图像特征中,边界( = 0.036)、形状( = 0.046)和微钙化( = 0.002)与 LNM 显著相关。在多因素分析中,BRAF V600E 突变相关 PTC 的 LNM 与年龄≤45 岁(OR = 1.869, = 0.020,95%CI = 1.106 - 3.158)、大小≥1cm(OR = 3.131, = 0.001,95%CI = 1.578 - 6.212)、US 中的 LNM(OR = 6.962, = 0.000,95%CI = 2.924 - 16.572)、双侧性(OR = 1.626, = 0.007,95%CI = 1.142 - 2.314)、US 中边界不清晰(OR = 1.980, = 0.033,95%CI = 1.057 - 3.709)和 US 中的微钙化(OR = 2.786, = 0.002,95%CI = 1.464 - 5.303)显著相关。
本研究表明,BRAF V600E 突变相关 PTC 发生 LNM 的几个显著风险因素包括:年龄≤45 岁、大小≥1cm、US 中的 LNM、双侧性、US 中边界不清晰和微钙化。